
Living with a rare medical condition is tough for patients and their families. Transthyretin amyloidosis happens when proteins fold wrong and build up in organs. This buildup can damage the heart or nerves if not treated.
Spotting the signs early is key to keeping well and living a good life. People often feel weak or have heart issues during everyday activities. Our team offers the medical help needed to tackle these challenges with care.
We aim to give top-notch support to those facing these tough times. Strong clinical oversight and accurate testing are critical for your health. Knowing how these protein clumps work helps us offer better care for each patient.
Key Takeaways
- Protein buildup leads to significant organ damage over several years.
- Early recognition prevents permanent heart and nerve harm.
- Common signs include exhaustion and numbness in the limbs.
- Specialized medical support enhances the patient quality of life.
- Accurate testing ensures a faster path to starting treatment.
- Managing protein deposits requires expert clinical oversight.
What Is ATTR Disease and How Does It Develop?

Transthyretin amyloidosis, or ATTR disease, happens when the transthyretin protein misfolds. ATTR disease is marked by amyloid fibrils, abnormal proteins that harm tissues. This leads to organ failure.
Transthyretin (TTR) is a liver-made protein. It carries vitamin A and thyroxine in the blood and cerebrospinal fluid. But in ATTR disease, TTR misfolds and forms amyloid fibrils. These fibrils build up in organs like the heart, nerves, and stomach.
Genetic mutations can cause TTR to misfold, leading to hereditary ATTR amyloidosis (hATTR or ATTRm). Without a known genetic cause, it leads to wild-type ATTR amyloidosis (wtATTR). Both types can cause serious health issues because the disease gets worse over time.
ATTR disease gets worse as amyloid deposits build up in organs. This causes different symptoms based on the affected organs.
| Organ/System | Symptoms/Effects |
| Heart (ATTR-CM) | Shortness of breath, fatigue, palpitations, and arrhythmias due to restrictive cardiomyopathy |
| Nervous System (ATTR-PN) | Peripheral neuropathy, autonomic dysfunction, and possible gastrointestinal issues |
| Gastrointestinal Tract | Nausea, vomiting, diarrhea or constipation, and weight loss |
Knowing how ATTR disease develops and gets worse is key for early treatment. As research grows, doctors can offer better care and support to patients.
Understanding the Two Types of ATTR Amyloidosis

ATTR amyloidosis comes in two types: hereditary and wild-type. These types have different causes, symptoms, and who they affect.
Hereditary ATTR Amyloidosis (hATTR or ATTRm)
Hereditary ATTR amyloidosis, or hATTR, is passed down from parents. It can start as early as 20 years old. The disease is caused by a genetic mutation that makes abnormal protein.
This protein builds up in tissues, mainly in nerves and the heart.
Key characteristics of hATTR include:
- Early onset, potentially in the second or third decade of life
- Family history of the condition
- Variable presentation, including neuropathy and cardiomyopathy
Wild-Type ATTR Amyloidosis (wtATTR)
Wild-type ATTR amyloidosis, or wtATTR, happens without a known genetic cause. It’s mostly found in people over 60. This type affects the heart most.
Key characteristics of wtATTR include:
- Late onset, typically after the age of 60
- No family history of the condition
- Primary involvement of the heart, leading to cardiomyopathy
Knowing the difference between these two types is key. It helps doctors choose the right treatment and gives patients the right information about their future.
| Characteristics | Hereditary ATTR Amyloidosis (hATTR) | Wild-Type ATTR Amyloidosis (wtATTR) |
| Cause | Genetic mutation in TTR gene | No known genetic cause |
| Age of Onset | As early as 20 years old | Typically over 60 years old |
| Primary Organs Affected | Nerves and heart | Heart |
Recognizing ATTR Amyloidosis Symptoms
Knowing the symptoms of ATTR amyloidosis is key to managing it. We’ll look at the signs of ATTR cardiac amyloidosis (ATTR-CM) and ATTR polyneuropathy (ATTR-PN).
ATTR Cardiac Amyloidosis Symptoms (ATTR-CM)
ATTR-CM happens when amyloid proteins build up in the heart. This causes the heart to stiffen, making it hard to fill with blood. Symptoms include:
- Shortness of breath, often when active
- Fatigue or feeling weak
- Swelling in the legs, ankles, and feet
- Irregular heartbeat or arrhythmias
- Dizziness or fainting spells
These signs happen because the amyloid makes the heart stiff. This can lead to heart failure if not treated.
ATTR Polyneuropathy Symptoms (ATTR-PN)
ATTR-PN damages the peripheral nerves. This causes various symptoms that can affect daily life. Common signs include:
- Numbness or tingling in the hands and feet
- Pain or burning sensations, often in the extremities
- Muscle weakness, mainly in the legs and hands
- Difficulty feeling the difference between hot and cold
- Autonomic dysfunction, leading to issues like orthostatic hypotension
These symptoms come from the amyloid damaging the nerves. This disrupts normal nerve function and communication with the brain.
We can summarize the key symptoms of ATTR-CM and ATTR-PN in the following table:
| Symptoms | ATTR-CM | ATTR-PN |
| Shortness of breath | Common | Rare |
| Fatigue | Common | Common |
| Numbness/Tingling | Occasional | Common |
| Irregular heartbeat | Common | Rare |
| Pain/Burning sensation | Rare | Common |
Conclusion
ATTR amyloidosis is a complex condition with various symptoms. It can be hard to diagnose. Recognizing these symptoms early is key for treatment.
The condition comes in different forms, like hereditary and wild-type ATTR amyloidosis. Each form has its own set of symptoms. Understanding these symptoms is important for early detection.
ATTR-CM symptoms can affect both men and women, causing heart issues. The heart’s functioning is often impacted. Early detection can help manage the disease better.
Pfizer has been leading in research and treatment for amyloidosis. This shows how vital ongoing medical research is in this field.
We’ve looked at the different types of ATTR amyloidosis and their symptoms. It’s important for healthcare providers and patients to be aware. By knowing the symptoms and treatments, we can slow the disease’s progression and improve patient outcomes.
FAQ
What is ATTR amyloidosis and how does it affect the body?
ATTR amyloidosis is a condition where abnormal transthyretin proteins accumulate as amyloid deposits in tissues. It can damage the heart, nerves, and other organs, leading to progressive dysfunction.
What is ATTRm and how is it different from the wild-type version?
ATTRm refers to hereditary transthyretin amyloidosis caused by gene mutations, whereas wild-type ATTR occurs without genetic mutations, typically in older adults. Both result in amyloid deposits but differ in onset and inheritance.
What are the most common ATTR cardiac amyloidosis symptoms to look for?
Common symptoms include heart failure signs like shortness of breath, fatigue, swelling in the legs, and irregular heartbeat. Early detection is important for managing cardiac complications.
Can you explain the symptoms of ATTR polyneuropathy (ATTR-PN)?
ATTR-PN affects peripheral nerves, causing numbness, tingling, weakness, and pain in the hands and feet. Symptoms often start in the lower extremities and gradually progress upwards.
What are the primary ATTR-CM causes?
ATTR-CM, or cardiac amyloidosis, is primarily caused by amyloid deposits from mutated or wild-type transthyretin. These deposits stiffen the heart muscle, impairing normal cardiac function.
How do we identify the general symptoms of ATTR amyloidosis in a clinical setting?
Clinicians look for signs such as neuropathy, heart failure, carpal tunnel syndrome, gastrointestinal issues, and unexplained weight loss. Diagnosis often requires imaging, biopsies, and genetic testing.
What is the significance of the term ATTR-CF in diagnosis?
ATTR-CF refers to the cardiac-focused form of ATTR amyloidosis, emphasizing heart involvement. Identifying this subtype helps guide treatment and monitor disease progression.
Are there specific resources available for those diagnosed with ATTR?
Yes, organizations and support groups provide information, patient education, and resources for managing ATTR. These include treatment guidance, clinical trial updates, and community support networks.
References
Nature. Evidence-Based Medical Insight. Retrieved from https://www.nature.com/articles/s41569-021-00672-8